Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Single-agent Filanesib in Advanced Multiple Myeloma
2014-001051-23Phase 2Completed
- Sponsor
- Array BioPharma
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of filanesib in multiple myeloma (MM) (2 arms), sponsored by Array BioPharma. Started Jun 2014; status: completed.
02
Drugs
filanesib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2014-001051-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001051-23.